BHASKAR RAJU: Open Payments
NPI 1558397620 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 62 payments from 14 companies in 2025. Trend: 2023 $3,361 · 2024 $1,757 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $226 |
| E.R. Squibb & Sons, L.L.C. | 6 | $139 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Corium, LLC | 5 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Alkermes, Inc. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Validus Pharmaceuticals LLC | 1 | $24 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Azstarys, INGREZZA, REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
